ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Mol Pharm Org Process Res 2024, Vol 12(4): 244

Surface Modification Techniques for Improving the Efficacy of Nanomedicines

Stanger Gadella*
Department of Pharmacognosy, Curtin University, Australia
*Corresponding Author: Stanger Gadella, Department of Pharmacognosy, Curtin University, Australia, Email: stanger.gadella@gmail.com

Received: 01-Jul-2024 / Manuscript No. JMPOPR-24-141926 / Editor assigned: 03-Jul-2024 / PreQC No. JMPOPR-24-141926(PQ) / Reviewed: 17-Jul-2024 / QC No. JMPOPR-24-141926 / Revised: 22-Jul-2024 / Manuscript No. JMPOPR-24-141926(R) / Published Date: 29-Jul-2024

Abstract

Nanomedicine has revolutionized drug delivery by offering precise targeting, controlled release, and enhanced therapeutic efficacy. Surface modification of nanoparticles plays a pivotal role in optimizing their pharmacokinetics, bio distribution, and biological interactions. This article reviews advanced surface modification techniques aimed at improving the efficacy of nanomedicines, focusing on strategies to enhance targeting specificity, evade immune recognition, and overcome biological barriers for superior clinical outcomes.

Keywords

Nanomedicine; Surface modification; Nanoparticles; Drug delivery; Targeting; Biocompatibility

Introduction

Nanomedicine represents a transformative approach to drug delivery and therapy, leveraging nanoparticles (NPs) for precise and efficient delivery of therapeutic agents. NPs offer unique advantages, including high surface area-to-volume ratio, tunable physicochemical properties, and the ability to encapsulate diverse payloads such as drugs, genes, or imaging agents. However, challenges such as nonspecific biodistribution, rapid clearance by the immune system, and insufficient targeting to diseased tissues necessitate sophisticated strategies to optimize NP performance [1].

Surface modification techniques are pivotal in tailoring NP properties to meet specific therapeutic requirements. These techniques involve the functionalization of NP surfaces with ligands, polymers, or coatings to enhance biocompatibility, prolong circulation time, and facilitate targeted delivery to desired tissues or cells. By modulating NP interactions with biological systems, surface modification strategies aim to improve drug efficacy, minimize side effects, and enable personalized medicine approaches [2,3].

This article explores advanced surface modification techniques aimed at improving the efficacy of nanomedicines. We discuss key strategies, mechanisms of action, and recent advancements in NP surface engineering to address challenges in drug delivery and therapeutic applications. By highlighting these innovations, we aim to underscore the transformative potential of surface-modified NPs in advancing precision medicine and enhancing patient outcomes [4].

Discussion

Targeting ligands and functional groups

Surface modification enables the conjugation of targeting ligands (e.g., antibodies, peptides, aptamers) to NPs, enhancing their specificity for diseased tissues or cells:

  1. Active targeting: Ligands bind to receptors overexpressed on target cells, facilitating NP internalization and enhancing therapeutic efficacy while minimizing off-target effects.
  2. Passive targeting: Surface modifications with hydrophilic polymers (e.g., polyethylene glycol, PEG) reduce NP opsonization, prolong circulation time, and enhance accumulation in leaky tumor vasculature via the enhanced permeability and retention (EPR) effect [5].

Stealth coatings and biomimetic approaches

Stealth coatings such as PEGylation shield NPs from immune recognition and clearance, improving their systemic circulation and reducing immunogenicity:

  1. PEGylation: Conjugation of PEG chains to NP surfaces imparts stealth properties, prolonging circulation half-life and enhancing drug delivery to target tissues.
  2. Cell membrane coatings: Biomimetic NPs coated with cell membranes (e.g., red blood cells, platelets) inherit biological functionalities (e.g., immune evasion, targeted homing), improving biocompatibility and reducing immune responses [6].

Responsive and stimuli-sensitive nanocarriers

Responsive NPs are designed to release payloads in response to specific stimuli (e.g., pH, enzymes, temperature) within diseased tissues or cellular microenvironments:

  1. pH-responsive NPs: Polymer or lipid-based NPs release drugs in acidic environments characteristic of tumors or inflamed tissues, enhancing therapeutic efficacy while minimizing systemic toxicity.
  2. Enzyme-sensitive NPs: NPs with enzyme-cleavable linkers selectively release payloads in response to elevated enzyme levels (e.g., matrix metalloproteinases) in diseased tissues, improving site-specific drug delivery [7].

Multifunctional nanoplatforms

Integration of multiple functionalities within NP platforms enhances their versatility and therapeutic potential:

  1. Theranostic NPs: Combined diagnostic (e.g., imaging agents) and therapeutic functionalities enable real-time monitoring of drug delivery and treatment efficacy.
  2. Combination therapy: NPs capable of co-delivering multiple therapeutic agents (e.g., drugs, genes) achieve synergistic effects, overcoming drug resistance and enhancing treatment outcomes [8].

Clinical translation and future perspectives

Despite significant advancements, the clinical translation of surface-modified NPs faces challenges including scalability, reproducibility, and regulatory approval:

  1. Scale-Up and manufacturing: Standardization of NP synthesis and scaling up production to ensure consistency and cost-effectiveness for clinical applications.
  2. Biocompatibility and safety: Comprehensive evaluation of NP biocompatibility, toxicity profiles, and long-term effects in preclinical and clinical studies.
  3. Regulatory considerations: Navigating regulatory pathways to obtain approval for clinical use, addressing safety concerns, and ensuring compliance with quality standards [9,10].

Conclusion

Surface modification techniques play a pivotal role in enhancing the efficacy and clinical applicability of nanomedicines by optimizing pharmacokinetics, targeting specificity, and therapeutic outcomes. By tailoring NP surfaces with advanced functionalities, researchers can overcome biological barriers, improve drug delivery efficiency, and enable personalized treatment strategies. Future research efforts should focus on refining surface modification strategies, addressing translational challenges, and advancing NP-based therapies towards transformative solutions in precision medicine and patient-centered healthcare.

Acknowledgement

None

Conflict of Interest

None

References

  1. Thao NT, Wanapat M, Kang S, Cherdthong A (2015)Effects of supplementation of eucalyptus (E. Camaldulensis) leaf meal on feed intake and rumen fermentation efficiency in swamp buffaloes.Asian-Australasian Journal of Animal Sciences 28: 951–957.
  2. Google Scholar, Crossref

  3. Gunun P, Gunun N, Cherdthong A, Wanapat M, Polyorach S, et al. (2018)In vitro rumen fermentation and methane production as affected by rambutan pee powder.Journal of Applied Animal Research 46: 626–631.
  4. Google Scholar, Crossref

  5. Kholif AE, Hassan AA, El Ashry GM, Bakr MH, El-Zaiat HM, et al. (2020)Phytogenic feed additives mixture enhances the lactational performance, feed utilization and ruminal fermentation of Friesian cows.Animal Biotechnology 1–11.
  6. Indexed at, Google Scholar, Crossref

  7. Neubauer V, Petri R, Humer E, Kröger I, Mann E, et al. (2018)High-grain diets supplemented with phytogenic compounds or autolyzed yeast modulate ruminal bacterial community and fermentation in dry cows.Journal of Dairy Science 101: 2335–2349.
  8. Indexed at, Google Scholar, Crossref

  9. Kholif AE, Matloup OH, Morsy TA, Abdo MM, Abu Elella AA, et al. (2017)Rosemary and lemongrass herbs as phytogenic feed additives to improve efficient feed utilization, manipulate rumen fermentation and elevate milk production of Damascus goats. Livestock Science 204: 39–46.
  10. Google Scholar, Crossref

  11. Akbarian-Tefaghi M, Ghasemi E, Khorvash M (2018)Performance, rumen fermentation and blood metabolites of dairy calves fed starter mixtures supplemented with herbal plants, essential oils or monensin.Journal of Animal Physiology and Animal Nutrition 102: 630–638.
  12. Indexed at, Google Scholar, Crossref

  13. Matloup OH, Abd El Tawab AM, Hassan AA, Hadhoud FI, Khattab MSA, et al. (2017)Performance of lactating Friesian cows fed a diet supplemented with coriander oil: Feed intake, nutrient digestibility, ruminal fermentation, blood chemistry, and milk production.Animal Feed Science and Technology 226: 88–97.
  14. Google Scholar, Crossref

  15. Parra-Garcia A, Elghandour MMMY, Greiner R, Barbabosa-Pliego A, Camacho-Diaz LM, et al. (2019)Effects of Moringa oleifera leaf extract on ruminal methane and carbon dioxide production and fermentation kinetics in a steer model.Environmental.Science and Pollution Research 26: 15333-15344.
  16. Indexed at, Google Scholar, Crossref

  17. Singh RK, Dey A, Paul SS, Singh M, Dahiya SS, et al. (2020)Associative effects of plant secondary metabolites in modulating in vitro methanogenesis, volatile fatty acids production and fermentation of feed in buffalo (Bubalus bubalis).Agroforestry Systems 94: 1555–1566.
  18. Google Scholar, Crossref

  19. Bhatta R, Saravanan M, Baruah L, Prasad CS (2015)Effects of graded levels of tannincontaining tropical tree leaves on in vitro rumen fermentation, total protozoa and methaneProduction.Journal of Applied  Microbiology 118: 557–564.
  20. Indexed at, Google Scholar, Crossref

Citation: Stanger G (2024) Surface Modification Techniques for Improving the Efficacy of Nanomedicines. J Mol Pharm Org Process Res 12: 244.

Copyright: © 2024 Stanger G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top